Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-07

Clinical Trial Update: LC Bead Embolization Agent With Doxorubicin in the Treatment Liver Metastasis From Melanoma [NA]

View source ↗

Summary

Clinical trial completed evaluation of LC Bead embolization with doxorubicin for liver metastases from melanoma; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LC Bead embolization agent with doxorubicin

Snippet

Sponsor: Robert C. Martin | Conditions: Stage IV Melanoma | NA | Status: COMPLETED | Results posted: 2018-06-07